Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?

Autor: Chen J; Taiwan Hepatitis Information & Care Association, Kaohsiung, Taiwan.; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA., Tu T; Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, New South Wales, Australia., Cohen C; Hepatitis B Foundation, Doylestown, Pennsylvania, USA., Wang S; Hepatitis B Foundation, Doylestown, Pennsylvania, USA.; Center for Asian Health, Cooperman Barnabas Medical Center, RWJBarnabas-Rutgers Medical Group, Livingston, New Jersey, USA., Hsu YC; Division of Gastroenterology and Hepatology, E-Da Hospital, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan., Gish RG; Hepatitis B Foundation, Doylestown, Pennsylvania, USA.; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.; Reno School of Medicine, University of Nevada, Reno, Nevada, USA.
Jazyk: angličtina
Zdroj: Hepatology (Baltimore, Md.) [Hepatology] 2024 May 01; Vol. 79 (5), pp. E132-E133. Date of Electronic Publication: 2023 Dec 26.
DOI: 10.1097/HEP.0000000000000732
Databáze: MEDLINE